Maxcyte Inc (MXCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -11,816 | -12,895 | N/A | N/A |
| Depreciation Amortization | 1,044 | 581 | N/A | N/A |
| Accounts receivable | -1,810 | 1,592 | N/A | N/A |
| Other Working Capital | -858 | 1,613 | N/A | N/A |
| Other Operating Activity | 4,659 | 307 | 0 | 0 |
| Operating Cash Flow | $-8,782 | $-8,803 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -14,506 | 1,726 | N/A | N/A |
| PPE Investments | -2,072 | -1,271 | N/A | N/A |
| Investing Cash Flow | $-16,578 | $455 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 1,440 | 4,953 | N/A | N/A |
| Debt Repayment | -1,504 | -5,106 | N/A | N/A |
| Common Stock Issued | 28,968 | 12,463 | N/A | N/A |
| Financing Cash Flow | $28,905 | $12,311 | $N/A | $N/A |
| Beginning Cash Position | 15,211 | 11,248 | N/A | N/A |
| End Cash Position | 18,755 | 15,211 | N/A | N/A |
| Net Cash Flow | $3,544 | $3,963 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -8,782 | -8,803 | N/A | N/A |
| Capital Expenditure | -2,072 | -1,271 | N/A | N/A |
| Free Cash Flow | -10,854 | -10,074 | 0 | 0 |